Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Adipokines, Inflammation, and Metabolic Diseases

141 та иш

  1. TYPE 2 DIABETES MELLITUS: GLOBAL EPIDEMIOLOGICAL TRENDS, MOLECULAR MECHANISMS AND RISK FACTORS WITH SPECIAL REFERENCE TO UZBEKISTAN

    D.R. Pazliddinova, I.R. Nusratullayev, A.V. Pazliddinov

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  2. КОМПЛЕКСНАЯ ДИАГНОСТИЧЕСКАЯ РОЛЬ БИОМАРКЕРОВ И РЕТИКУЛОЦИТОВ В ОЦЕНКЕ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ ПРИ САХАРНОМ ДИАБЕТЕ

    Фарангиз Садриддиновна Набиева, Гулбадан Завқиддин қизи Бадирдинова

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  3. КОМПЛЕКСНАЯ ДИАГНОСТИЧЕСКАЯ РОЛЬ БИОМАРКЕРОВ И РЕТИКУЛОЦИТОВ В ОЦЕНКЕ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ ПРИ САХАРНОМ ДИАБЕТЕ

    Фарангиз Садриддиновна Набиева, Гулбадан Завқиддин қизи Бадирдинова

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  4. "DIABETES MELLITUS: CAUSES, TREATMENT METHODS, AND MICROBIOLOGICAL FOUNDATIONS"

    Muxabbat Ergashovna Djurayeva, Diyorbek Orifjon ugli Ergashov, Shuhrat Ulmasjon ugli Yuldoshov

    МақолаGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  5. "DIABETES MELLITUS: CAUSES, TREATMENT METHODS, AND MICROBIOLOGICAL FOUNDATIONS"

    Muxabbat Ergashovna Djurayeva, Diyorbek Orifjon ugli Ergashov, Shuhrat Ulmasjon ugli Yuldoshov

    МақолаGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  6. QANDLI DIABET KASALLIGIDA BITMAYDIGAN YARALAR VA GANGRENANI OLDINI OLISHDA "HELP DIABETIC" SURTMASINING AHAMIYATI

    Sitoraxon Saidova, Zilola Abdijalilova

    МақолаEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  7. QANDLI DIABET KASALLIGIDA BITMAYDIGAN YARALAR VA GANGRENANI OLDINI OLISHDA "HELP DIABETIC" SURTMASINING AHAMIYATI

    Sitoraxon Saidova, Zilola Abdijalilova

    МақолаEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  8. Dynamics of Insulin Resistance in The Aspect of Medical Biology

    M.M. Shertaev

    МақолаImmunotoxicology and immune responsesThe American Journal of Medical Sciences and Pharmaceutical Research20260 иқтибос
    ABI

  9. RISK FACTORS FOR DRY EYE SYNDROME AMONG MILITARY PERSONNEL IN ARID CLIMATE CONDITIONS

    A.M. Nabiev, S.B. Fayzieva

    МақолаRegulation of Appetite and ObesityZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  10. RISK FACTORS FOR DRY EYE SYNDROME AMONG MILITARY PERSONNEL IN ARID CLIMATE CONDITIONS

    A.M. Nabiev, S.B. Fayzieva

    МақолаRegulation of Appetite and ObesityZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  11. Immunometabolic Predictors Of Diabetic Foot Syndrome In Type 2 Diabetes Mellitus

    Rakhmonov Nodir Nuritdinovich, Nazirkulov Olimjan Maxmudjonov, Azizova Zukhra Shukhratovna +1

    МақолаDiabetic Foot Ulcer Assessment and ManagementAmerican Journal Of Social Sciences And Humanity Research20260 иқтибос
    ABI

  12. IL-6 AND FGF-23 AS EARLY BIOMARKERS OF LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE RISK IN DIABETES MELLITUS

    Volha Vasilkova, Tatsiana Mokhort, Natalia Khudiakova +2

    МақолаAdipokines, Inflammation, and Metabolic DiseasesJournal of Hypertension20260 иқтибос
    ABI

  13. YURAK YETISHMOVCHILIGIDA BIOKIMYOVIY MARKERLAR

    Numonova Marjona, Axmadjonov Qudratillo

    МақолаAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  14. YURAK YETISHMOVCHILIGIDA BIOKIMYOVIY MARKERLAR

    Numonova Marjona, Axmadjonov Qudratillo

    МақолаAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  15. ATEROSKLEROZ VA SURUNKALI YALLIG'LANISH: PATOGENEZ, KLINIK AHAMIYAT VA PROFILAKTIK YONDASHUVLAR

    Olimova Zohida Iqboljon qizi, Moydinova Nurxon Mirzayevna

    МақолаAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  16. ATEROSKLEROZ VA SURUNKALI YALLIG'LANISH: PATOGENEZ, KLINIK AHAMIYAT VA PROFILAKTIK YONDASHUVLAR

    Olimova Zohida Iqboljon qizi, Moydinova Nurxon Mirzayevna

    МақолаAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  17. Physical activity is associated with improved glycemic control but not with IL-6–glycemic interactions in type 2 diabetes: a cross-sectional study

    M Ismail, Mutaz Ibrahim Hassan, Amged Gaffer Mostafa +10

    МақолаAdipokines, Inflammation, and Metabolic DiseasesFrontiers in Endocrinology20260 иқтибос
    ABI

  18. QANDLI DIABETNING BIOKIMYOVIY ASOSLARI VA UNING TAHLILI

    Mashrabov Abduvahob Maqsudbek o'g'li, Ahmadjonov Qudratillo Mashrabboy o'g'li

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  19. QANDLI DIABETNING BIOKIMYOVIY ASOSLARI VA UNING TAHLILI

    Mashrabov Abduvahob Maqsudbek o'g'li, Ahmadjonov Qudratillo Mashrabboy o'g'li

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  20. YURAK -QON TOMIR KASALLIKLAR BIOKIMYOSI

    Ashurova Guljamol Mansurbek qizi, Ahmadjonov Qudratillo Mashrabboy o'g'li

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  21. YURAK -QON TOMIR KASALLIKLAR BIOKIMYOSI

    Ashurova Guljamol Mansurbek qizi, Ahmadjonov Qudratillo Mashrabboy o'g'li

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  22. NOALKOGOLLI JIGAR GEPATOZINING SHAKLLANISHI VA RIVOJLANISHIDA SELEKTINLARNING ROLI

    Ro'zimova Gulhayo

    МақолаEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  23. NOALKOGOLLI JIGAR GEPATOZINING SHAKLLANISHI VA RIVOJLANISHIDA SELEKTINLARNING ROLI

    Ro'zimova Gulhayo

    МақолаEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  24. METABOLIK SINDROM SHAROITIDA A'ZO VA TО'QIMALARNING TIZIMLI SHIKASTLANISHINING PATOGENETIK MEXANIZMLARI

    Maftuna Xolboyeva

    МақолаAdipokines, Inflammation, and Metabolic DiseasesOpen MIND20260 иқтибос
    ABI

  25. METABOLIK SINDROM SHAROITIDA A'ZO VA TО'QIMALARNING TIZIMLI SHIKASTLANISHINING PATOGENETIK MEXANIZMLARI

    Maftuna Xolboyeva

    МақолаAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI